Differential Diagnosis of Diarrhea in Patients With Neuroendocrine Tumors
Year: 2020
Type: review
Abstract: Patients with neuroendocrine tumors (NETs) and carcinoid syndrome experience diarrhea that can have a debilitating effect on quality of life. Diarrhea also may develop in response to other hormonal syndromes associated with NETs, surgical complications, medical comorbidities, medications, or food sensitivities. Limited guidance on the practical approach to the differential diagnosis of diarrhea in these patients can lead to delays in appropriate treatment. This clinical review and commentary underscore the complexity in identifying the etiology of diarrhea in patients with NETs. Based on our collective experience and expertise, we offer a practical algorithm to guide medical oncologists and other care providers to expedite effective management of diarrhea and related symptoms in patients with NETs.
Source: Pancreas
Authors: Jennifer R. Eads, Diane Reidy-Lagunes, Heloisa P. Soares, Jennifer A. Chan, Lowell B. Anthony, Thorvardur R. Halfdanarson, Boris G. Naraev, Edward M. Wolin, Daniel M. Halperin, Daneng Li, Rodney F. Pommier, Jerome S. Zacks, Michael A. Morse, David C. Metz, from the Carcinoid Syndrome Control Collaborative
Institutions: Abramson Cancer Center, University of Pennsylvania, Memorial Sloan Kettering Cancer Center, University of Utah, Huntsman Cancer Institute, Harvard University, Dana-Farber Cancer Institute, University of Kentucky, Markey Cancer Center, Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota), The University of Texas MD Anderson Cancer Center, Banner MD Anderson Cancer Center, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, City Of Hope National Medical Center, City of Hope, Beckman Research Institute, Oregon Health & Science University, Duke Medical Center
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W3090815474